TCW Group’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
TCW Group's IDXX Position: Q3 2026 in Review
TCW Group reduced its Idexx Laboratories (IDXX) stake by 14% in Q3 2026, selling an estimated $8.27M and leaving 93,858 shares worth $49M. The position accounts for 0.38% of the portfolio, ranked #69.
TCW Group first reported a position in IDXX in Q4 2017 and has held it in 13 quarters since. The position peaked at $66.7M in Q1 2026. 1,281 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.
- TCW Group held 93,858 shares of Idexx Laboratories worth $49M as of Q3 2026.
- TCW Group sold 15,093 Idexx Laboratories shares in Q3 2026, an estimated $8.27M.
- Idexx Laboratories made up 0.38% of TCW Group's portfolio in Q3 2026, its #69 holding.
- TCW Group first reported a position in Idexx Laboratories in Q4 2017 and has held it in 13 quarters since.
- TCW Group's Idexx Laboratories position peaked at $66.7M in Q1 2026.
- 1,281 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.
Based on TCW Group's 13F filing for Q3 2026, filed 10 Nov 2026.